Details of the Drug Combinations

General Information of This Drug (ID: DMINOX3)

Drug Name
Vincristine   DMINOX3
Synonyms
LCR; Leurocristine; Marqibo; Oncovine; Tecnocris; VCR; VIN; Vincasar; Vincristina; Vincristinum; Vincrstine; Vincrystine; Vinkristin; Indole alkaloid; Liposomal Vincristine; Onco TCS; Vincristina [DCIT]; Oncovin (TN); Tecnocris (TN); Vincristine (INN); Vincristine [INN:BAN]; Vincristinum [INN-Latin]; Lilly37231 (1:1 sulfate salt); Oncovin (1:1 sulfate salt); Vincasar (1:1 sulfate salt); Vincrex (1:1 sulfate salt); Vincaleukoblastine, 22-oxo-22-Oxovincaleukoblastine; Z-D-Val-Lys(Z)-OH; 22-Oxovincaleukoblastine
Indication
Disease Entry ICD 11 Status REF
Acute lymphoblastic leukaemia 2A85 Approved [1]
Adult kidney Wilms tumor N.A. Approved [2]
Beckwith-Wiedemann syndrome N.A. Approved [2]
Burkitt lymphoma N.A. Approved [2]
Central nervous system neoplasm N.A. Approved [2]
Childhood acute lymphoblastic leukemia N.A. Approved [2]
Childhood kidney Wilms tumor N.A. Approved [2]
Hamartoma N.A. Approved [2]
Kidney neoplasm N.A. Approved [2]
Leukemia N.A. Approved [2]
MALT lymphoma N.A. Approved [2]
Nodal marginal zone lymphoma 2A85.0 Approved [2]
Plasma cell myeloma 2A83.1 Approved [2]
Primitive neuroectodermal tumor N.A. Approved [2]
Splenic marginal zone lymphoma N.A. Approved [2]
Testicular lymphoma N.A. Approved [2]
Wilms tumor N.A. Approved [2]
Classic Hodgkin lymphoma N.A. Investigative [2]
Follicular lymphoma 2A80 Investigative [2]
Neuroblastoma 2D11.2 Investigative [2]
⏷ Show the Full List of Indication(s)
Therapeutic Class
Anticancer Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

599 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
(-)-englerin A + Vincristine DC14MGP (-)-englerin A Ewing sarcoma (Cell Line: TC-71) [3]
ABIRATERONE + Vincristine DC9HHV9 ABIRATERONE Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
ABIRATERONE + Vincristine DC95AF7 ABIRATERONE Anaplastic large cell lymphoma (Cell Line: SR) [3]
ABIRATERONE + Vincristine DCN8WVN ABIRATERONE Chronic myelogenous leukemia (Cell Line: K-562) [3]
ABIRATERONE + Vincristine DCCR03I ABIRATERONE Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
ABIRATERONE + Vincristine DCGKC3Z ABIRATERONE Papillary renal cell carcinoma (Cell Line: ACHN) [3]
ABIRATERONE + Vincristine DCV4KGM ABIRATERONE Renal cell carcinoma (Cell Line: UO-31) [3]
ABIRATERONE + Vincristine DCYJ5J5 ABIRATERONE Renal cell carcinoma (Cell Line: SN12C) [3]
ABIRATERONE + Vincristine DCL1IZW ABIRATERONE Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
ABIRATERONE + Vincristine DCFOMSM ABIRATERONE Carcinoma (Cell Line: MCF7) [4]
ABIRATERONE + Vincristine DCF5WWX ABIRATERONE Adenocarcinoma (Cell Line: OVCAR3) [5]
ABIRATERONE + Vincristine DC2IF08 ABIRATERONE Adenocarcinoma (Cell Line: HCT-15) [5]
ABIRATERONE + Vincristine DC5KYNC ABIRATERONE Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
ABIRATERONE + Vincristine DC90QTP ABIRATERONE High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
ABIRATERONE + Vincristine DCQMPZK ABIRATERONE Large cell lung carcinoma (Cell Line: NCI-H460) [5]
ABIRATERONE + Vincristine DC0NX5E ABIRATERONE Lung adenocarcinoma (Cell Line: NCI-H522) [5]
ABIRATERONE + Vincristine DCNZ7PF ABIRATERONE Malignant melanoma (Cell Line: LOX IMVI) [5]
ABT-263 + Vincristine DCVTIAL ABT-263 Ewing sarcoma (Cell Line: TC-71) [5]
Amonafide + Vincristine DCOVWI2 Amonafide Adenocarcinoma (Cell Line: DU-145) [3]
Amonafide + Vincristine DCFMQZ0 Amonafide Adenocarcinoma (Cell Line: A549) [3]
Amonafide + Vincristine DCVFX46 Amonafide Adenocarcinoma (Cell Line: SW-620) [3]
Amonafide + Vincristine DCZ1STM Amonafide Adenocarcinoma (Cell Line: HCT116) [3]
Amonafide + Vincristine DCGARNE Amonafide Adenocarcinoma (Cell Line: HCT-15) [3]
Amonafide + Vincristine DCDPHB1 Amonafide Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Amonafide + Vincristine DCK4QWA Amonafide Astrocytoma (Cell Line: U251) [3]
Amonafide + Vincristine DC2HR4A Amonafide Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Amonafide + Vincristine DCS8I24 Amonafide Clear cell renal cell carcinoma (Cell Line: A498) [3]
Amonafide + Vincristine DCHLWSL Amonafide Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Amonafide + Vincristine DC4K52B Amonafide Glioma (Cell Line: SF-268) [3]
Amonafide + Vincristine DCOE57D Amonafide Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Amonafide + Vincristine DCC6WVF Amonafide Lung adenocarcinoma (Cell Line: HOP-62) [3]
Amonafide + Vincristine DCMBB49 Amonafide Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Amonafide + Vincristine DCY319L Amonafide Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Amonafide + Vincristine DC7EHVI Amonafide Invasive ductal carcinoma (Cell Line: BT-549) [4]
Anastrozole + Vincristine DCDE3F9 Anastrozole Adenocarcinoma (Cell Line: A549) [3]
Anastrozole + Vincristine DC0KO9Y Anastrozole Adenocarcinoma (Cell Line: HCT-15) [3]
Anastrozole + Vincristine DCUG9B3 Anastrozole Adenocarcinoma (Cell Line: SW-620) [3]
Anastrozole + Vincristine DCFZD1N Anastrozole Adenocarcinoma (Cell Line: HCT116) [3]
Anastrozole + Vincristine DC9O1VM Anastrozole Adenocarcinoma (Cell Line: HT29) [3]
Anastrozole + Vincristine DC3I1QA Anastrozole Amelanotic melanoma (Cell Line: M14) [3]
Anastrozole + Vincristine DCUWS8K Anastrozole Astrocytoma (Cell Line: SNB-19) [3]
Anastrozole + Vincristine DCCBQ7Y Anastrozole Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Vincristine DCA8ZI7 Anastrozole Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Anastrozole + Vincristine DCINFPH Anastrozole Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Anastrozole + Vincristine DCJ9656 Anastrozole Clear cell renal cell carcinoma (Cell Line: A498) [3]
Anastrozole + Vincristine DCSGKBT Anastrozole Glioma (Cell Line: SF-295) [3]
Anastrozole + Vincristine DCMB0CR Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + Vincristine DCET9P5 Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Anastrozole + Vincristine DCGFMQ3 Anastrozole Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + Vincristine DCIFU9Q Anastrozole Lung adenocarcinoma (Cell Line: HOP-62) [3]
Anastrozole + Vincristine DC2X725 Anastrozole Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Anastrozole + Vincristine DC5UJ1M Anastrozole Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Vincristine DCFZP9V Anastrozole Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Anastrozole + Vincristine DCKEV60 Anastrozole Invasive ductal carcinoma (Cell Line: BT-549) [4]
Arfolitixorin + Vincristine DCTONSL Arfolitixorin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Arfolitixorin + Vincristine DC19SOM Arfolitixorin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Arfolitixorin + Vincristine DCEL0Y8 Arfolitixorin Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
AZD8055 + Vincristine DC0X3B5 AZD8055 Ewing sarcoma (Cell Line: TC-71) [3]
Bafilomycin A1 + Vincristine DCOFGY1 Bafilomycin A1 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
BIO-300 + Vincristine DCFXLB3 BIO-300 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
BIO-300 + Vincristine DCREU0P BIO-300 Anaplastic large cell lymphoma (Cell Line: SR) [3]
BIO-300 + Vincristine DC52PE0 BIO-300 Astrocytoma (Cell Line: U251) [3]
BIO-300 + Vincristine DC0EHOB BIO-300 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
BIO-300 + Vincristine DCKXUPC BIO-300 Chronic myelogenous leukemia (Cell Line: K-562) [3]
BIO-300 + Vincristine DCSY7LN BIO-300 Clear cell renal cell carcinoma (Cell Line: A498) [3]
BIO-300 + Vincristine DCXYX9X BIO-300 Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
BIO-300 + Vincristine DC5M3DL BIO-300 Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
BIO-300 + Vincristine DC4U7HV BIO-300 Glioma (Cell Line: SF-268) [3]
BIO-300 + Vincristine DCYOJTX BIO-300 Glioma (Cell Line: SF-539) [3]
BIO-300 + Vincristine DC3DUFW BIO-300 Glioma (Cell Line: SF-295) [3]
BIO-300 + Vincristine DC6LBV9 BIO-300 Renal cell carcinoma (Cell Line: SN12C) [3]
BIO-300 + Vincristine DCHXL81 BIO-300 Carcinoma (Cell Line: RXF 393) [4]
BIO-300 + Vincristine DC2X6UN BIO-300 Carcinoma (Cell Line: MCF7) [4]
BIO-300 + Vincristine DCPD3VR BIO-300 Colon adenocarcinoma (Cell Line: COLO 205) [4]
BIO-300 + Vincristine DCAEIHX BIO-300 Adenocarcinoma (Cell Line: DU-145) [5]
BIO-300 + Vincristine DCT0YWC BIO-300 Adenocarcinoma (Cell Line: OVCAR3) [5]
BIO-300 + Vincristine DCKPBVF BIO-300 Adenocarcinoma (Cell Line: NCIH23) [5]
BIO-300 + Vincristine DC6IXPW BIO-300 Adenocarcinoma (Cell Line: A549) [5]
BIO-300 + Vincristine DCA8125 BIO-300 Adenocarcinoma (Cell Line: HCT-15) [5]
BIO-300 + Vincristine DCNF0QM BIO-300 Adenocarcinoma (Cell Line: SW-620) [5]
BIO-300 + Vincristine DC6DSUS BIO-300 Adenocarcinoma (Cell Line: HCT116) [5]
BIO-300 + Vincristine DCSUW6Q BIO-300 Amelanotic melanoma (Cell Line: M14) [5]
BIO-300 + Vincristine DCVFN7D BIO-300 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
BIO-300 + Vincristine DCWMU5H BIO-300 Large cell lung carcinoma (Cell Line: NCI-H460) [5]
BIO-300 + Vincristine DC0DFK4 BIO-300 Lung adenocarcinoma (Cell Line: HOP-62) [5]
BIO-300 + Vincristine DCP5CBG BIO-300 Malignant melanoma (Cell Line: UACC62) [5]
BIO-300 + Vincristine DC3M762 BIO-300 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
BIO-300 + Vincristine DCQCZ2Q BIO-300 Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
BIO-300 + Vincristine DC7MK4Y BIO-300 Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
BIO-300 + Vincristine DCX2L4H BIO-300 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
BIO-300 + Vincristine DCGKVQS BIO-300 Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Bleomycin + Vincristine DCESYL9 Bleomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Bleomycin + Vincristine DCZJG1H Bleomycin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Bleomycin + Vincristine DCDJAI6 Bleomycin Clear cell renal cell carcinoma (Cell Line: A498) [3]
Bleomycin + Vincristine DCQ26FS Bleomycin Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Bleomycin + Vincristine DCE1Y75 Bleomycin Glioma (Cell Line: SF-295) [3]
Bleomycin + Vincristine DCWJMN4 Bleomycin Adenocarcinoma (Cell Line: DU-145) [5]
Bleomycin + Vincristine DCR7XY0 Bleomycin Adenocarcinoma (Cell Line: OVCAR3) [5]
Bleomycin + Vincristine DCWP8O3 Bleomycin Adenocarcinoma (Cell Line: A549) [5]
Bleomycin + Vincristine DCQGQYQ Bleomycin Adenocarcinoma (Cell Line: HCT-15) [5]
Bleomycin + Vincristine DCCY0WI Bleomycin Amelanotic melanoma (Cell Line: M14) [5]
Bleomycin + Vincristine DCO1PRX Bleomycin Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Bleomycin + Vincristine DC6UVDY Bleomycin Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Bleomycin + Vincristine DCTBBYT Bleomycin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Cabazitaxel + Vincristine DC0X5FB Cabazitaxel Adenocarcinoma (Cell Line: DU-145) [3]
Cabazitaxel + Vincristine DCHR3JP Cabazitaxel Adenocarcinoma (Cell Line: OVCAR3) [3]
Cabazitaxel + Vincristine DCWN328 Cabazitaxel Adenocarcinoma (Cell Line: HCT-15) [3]
Cabazitaxel + Vincristine DCRT3BG Cabazitaxel Adenocarcinoma (Cell Line: HCC-2998) [3]
Cabazitaxel + Vincristine DCV5J7A Cabazitaxel Adenocarcinoma (Cell Line: HCT116) [3]
Cabazitaxel + Vincristine DCLJSXB Cabazitaxel Adenocarcinoma (Cell Line: HT29) [3]
Cabazitaxel + Vincristine DCT8VKH Cabazitaxel Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Cabazitaxel + Vincristine DCKJ4NN Cabazitaxel Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Cabazitaxel + Vincristine DC35GTA Cabazitaxel Anaplastic large cell lymphoma (Cell Line: SR) [3]
Cabazitaxel + Vincristine DCCZ7OK Cabazitaxel Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Cabazitaxel + Vincristine DC6FJ7Q Cabazitaxel Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Cabazitaxel + Vincristine DCM8W84 Cabazitaxel Glioma (Cell Line: SF-539) [3]
Cabazitaxel + Vincristine DCNP0PM Cabazitaxel Glioma (Cell Line: SF-295) [3]
Cabazitaxel + Vincristine DC9ZEF7 Cabazitaxel High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Cabazitaxel + Vincristine DCC7BHU Cabazitaxel Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Cabazitaxel + Vincristine DCAT2EX Cabazitaxel Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Cabazitaxel + Vincristine DCVX2JS Cabazitaxel Malignant melanoma (Cell Line: UACC62) [3]
Cabazitaxel + Vincristine DCFQXR9 Cabazitaxel Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Cabazitaxel + Vincristine DCR36OI Cabazitaxel Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Cabazitaxel + Vincristine DCREWE5 Cabazitaxel Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Cabazitaxel + Vincristine DCP63RT Cabazitaxel Prostate carcinoma (Cell Line: PC-3) [3]
Cabazitaxel + Vincristine DCPGT88 Cabazitaxel Renal cell carcinoma (Cell Line: SN12C) [3]
Cabazitaxel + Vincristine DC414L0 Cabazitaxel Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Cabazitaxel + Vincristine DC8MV6Z Cabazitaxel Carcinoma (Cell Line: RXF 393) [4]
Cabazitaxel + Vincristine DC84J5F Cabazitaxel Carcinoma (Cell Line: MCF7) [4]
Cabazitaxel + Vincristine DCF7AH2 Cabazitaxel Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Cabazitaxel + Vincristine DCUVW85 Cabazitaxel Invasive ductal carcinoma (Cell Line: BT-549) [4]
Crizotinib + Vincristine DCJXL4P Crizotinib Adenocarcinoma (Cell Line: HCT-15) [3]
Crizotinib + Vincristine DCDCO2M Crizotinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Crizotinib + Vincristine DCT3NOA Crizotinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Crizotinib + Vincristine DC30A64 Crizotinib Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Crizotinib + Vincristine DC3KQW9 Crizotinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Crizotinib + Vincristine DCAWKQ9 Crizotinib Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Crizotinib + Vincristine DCSM9MF Crizotinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Crizotinib + Vincristine DCF3ODJ Crizotinib Glioma (Cell Line: SF-295) [3]
Crizotinib + Vincristine DCK5WQK Crizotinib Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Crizotinib + Vincristine DCDHGEZ Crizotinib Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Dacarbazine + Vincristine DCJ1ZIR Dacarbazine Adenocarcinoma (Cell Line: HCT-15) [3]
Dacarbazine + Vincristine DCPO0CF Dacarbazine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + Vincristine DCQ7ESX Dacarbazine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Dacarbazine + Vincristine DCW8CA2 Dacarbazine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + Vincristine DCX39CA Dacarbazine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Dacarbazine + Vincristine DC5EE5S Dacarbazine Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Dacarbazine + Vincristine DCYPJFB Dacarbazine Glioma (Cell Line: SF-295) [3]
Dacarbazine + Vincristine DC7SCZR Dacarbazine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Dacarbazine + Vincristine DC54IJ7 Dacarbazine Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Dacarbazine + Vincristine DCXV6UL Dacarbazine Invasive ductal carcinoma (Cell Line: BT-549) [4]
Dactinomycin + Vincristine DCISZLJ Dactinomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dactinomycin + Vincristine DC21LAN Dactinomycin Chronic myelogenous leukemia (Cell Line: K-562) [5]
Decitabine + Vincristine DCLSE9A Decitabine Ewing sarcoma (Cell Line: TC-71) [3]
Dexrazoxane + Vincristine DC9B1RY Dexrazoxane Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dexrazoxane + Vincristine DC7BS8N Dexrazoxane Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dexrazoxane + Vincristine DCUV444 Dexrazoxane Clear cell renal cell carcinoma (Cell Line: A498) [3]
Dexrazoxane + Vincristine DCD22N9 Dexrazoxane Adenocarcinoma (Cell Line: OVCAR3) [5]
Dexrazoxane + Vincristine DCSQAAB Dexrazoxane Adenocarcinoma (Cell Line: A549) [5]
Dexrazoxane + Vincristine DCM7DXS Dexrazoxane Amelanotic melanoma (Cell Line: M14) [5]
DFN-15 + Vincristine DCY7STK DFN-15 Lung adenocarcinoma (Cell Line: HOP-62) [5]
DFN-15 + Vincristine DCFQORL DFN-15 Lung adenocarcinoma (Cell Line: EKVX) [5]
Epirubicin + Vincristine DCHYXOW Epirubicin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Epirubicin + Vincristine DCN0O2C Epirubicin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Epirubicin + Vincristine DC8S1V4 Epirubicin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Epirubicin + Vincristine DC13ZJD Epirubicin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Epirubicin + Vincristine DC1IA7L Epirubicin Renal cell carcinoma (Cell Line: UO-31) [3]
Epirubicin + Vincristine DCOYF5D Epirubicin Renal cell carcinoma (Cell Line: SN12C) [3]
Epirubicin + Vincristine DC9JM6C Epirubicin Adenocarcinoma (Cell Line: OVCAR3) [5]
Epirubicin + Vincristine DCK7YDA Epirubicin Adenocarcinoma (Cell Line: HCT-15) [5]
Epirubicin + Vincristine DCSTN8L Epirubicin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Erlotinib + Vincristine DCVY1OQ Erlotinib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Everolimus + Vincristine DCFH9CN Everolimus Ewing sarcoma (Cell Line: TC-71) [3]
Exherin + Vincristine DCKZP5Y Exherin Ewing sarcoma (Cell Line: TC-71) [3]
Fludarabine + Vincristine DC25L5A Fludarabine Colon carcinoma (Cell Line: KM12) [4]
Fludarabine + Vincristine DC1O002 Fludarabine Lung adenocarcinoma (Cell Line: EKVX) [5]
Gefitinib + Vincristine DCHXHGU Gefitinib Adenocarcinoma (Cell Line: DU-145) [3]
Gefitinib + Vincristine DCBFMM5 Gefitinib Adenocarcinoma (Cell Line: A549) [3]
Gefitinib + Vincristine DCNUET5 Gefitinib Adenocarcinoma (Cell Line: HCT-15) [3]
Gefitinib + Vincristine DCWVYE6 Gefitinib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Gefitinib + Vincristine DCH78SP Gefitinib Chronic myelogenous leukemia (Cell Line: K-562) [3]
Gefitinib + Vincristine DCJI3VN Gefitinib Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Gefitinib + Vincristine DC6QTMH Gefitinib Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Gefitinib + Vincristine DCOTSD0 Gefitinib Glioma (Cell Line: SF-295) [3]
Gefitinib + Vincristine DCVMNUI Gefitinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Gefitinib + Vincristine DCA6XXA Gefitinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Gefitinib + Vincristine DCYL7ET Gefitinib Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Gefitinib + Vincristine DC5CNPQ Gefitinib Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Gefitinib + Vincristine DCC5HEN Gefitinib Lung adenocarcinoma (Cell Line: HOP-62) [3]
Gefitinib + Vincristine DC3GBRB Gefitinib Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Gefitinib + Vincristine DCO1YE0 Gefitinib Malignant melanoma (Cell Line: LOX IMVI) [3]
Gefitinib + Vincristine DCMCWM3 Gefitinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Gefitinib + Vincristine DCPVUBY Gefitinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Gefitinib + Vincristine DC4LX6M Gefitinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Gefitinib + Vincristine DC3NYG2 Gefitinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Gefitinib + Vincristine DCRW7R9 Gefitinib Prostate carcinoma (Cell Line: PC-3) [3]
Gefitinib + Vincristine DCSTU4J Gefitinib Renal cell carcinoma (Cell Line: SN12C) [3]
Gefitinib + Vincristine DCJZ96R Gefitinib Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Indazole derivative 5 + Vincristine DC0BF6L Indazole derivative 5 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Indazole derivative 5 + Vincristine DCXY8WF Indazole derivative 5 Anaplastic large cell lymphoma (Cell Line: SR) [3]
Indazole derivative 5 + Vincristine DCPKADF Indazole derivative 5 Adenocarcinoma (Cell Line: HCT116) [5]
Indazole derivative 5 + Vincristine DC4ZRU5 Indazole derivative 5 Adenocarcinoma (Cell Line: HCT-15) [5]
Indazole derivative 5 + Vincristine DCJ7Y6E Indazole derivative 5 Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Indazole derivative 5 + Vincristine DCETF9I Indazole derivative 5 Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Indazole derivative 5 + Vincristine DCHA12A Indazole derivative 5 Malignant melanoma (Cell Line: UACC62) [5]
JNK-IN-8 + Vincristine DCEEHZV JNK-IN-8 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
JNK-IN-8 + Vincristine DCKJ2JB JNK-IN-8 Clear cell renal cell carcinoma (Cell Line: A498) [3]
JNK-IN-8 + Vincristine DCWP1FH JNK-IN-8 Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
JNK-IN-8 + Vincristine DCRKYAV JNK-IN-8 Adenocarcinoma (Cell Line: DU-145) [5]
JNK-IN-8 + Vincristine DCRMNJ0 JNK-IN-8 Adenocarcinoma (Cell Line: HCT-15) [5]
Lenalidomide + Vincristine DCI74WO Lenalidomide Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Lenalidomide + Vincristine DCVQV96 Lenalidomide Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Letrozole + Vincristine DCCKQ6E Letrozole Lung adenocarcinoma (Cell Line: HOP-62) [3]
LIAROZOLE + Vincristine DCKTQE7 LIAROZOLE Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
LIAROZOLE + Vincristine DCXT5I5 LIAROZOLE Adenocarcinoma (Cell Line: HCT-15) [5]
LIAROZOLE + Vincristine DCMTIHE LIAROZOLE Lung adenocarcinoma (Cell Line: EKVX) [5]
LY2835219 + Vincristine DCEG21B LY2835219 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
LY2874455 + Vincristine DCQ2TLV LY2874455 Ewing sarcoma (Cell Line: TC-71) [3]
Mechlorethamine + Vincristine DCEJEEI Mechlorethamine Clear cell renal cell carcinoma (Cell Line: A498) [3]
Mitapivat + Vincristine DC7JEQH Mitapivat Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
MK-1775 + Vincristine DC0PERD MK-1775 Ewing sarcoma (Cell Line: TC-71) [3]
Ombrabulin + Vincristine DCD1GQD Ombrabulin Ewing sarcoma (Cell Line: TC-71) [3]
Pelitinib + Vincristine DCDRNQT Pelitinib Hodgkin lymphoma (Cell Line: L-1236) [5]
Picoplatin + Vincristine DCZ51V3 Picoplatin Clear cell renal cell carcinoma (Cell Line: A498) [3]
Picoplatin + Vincristine DCZWP3D Picoplatin Renal cell carcinoma (Cell Line: SN12C) [3]
Picoplatin + Vincristine DCF8N8W Picoplatin Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Raloxifene + Vincristine DCL7IJ4 Raloxifene Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Raloxifene + Vincristine DC0NUL5 Raloxifene High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Ridaforolimus + Vincristine DC2VYN8 Ridaforolimus Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
SCH 727965 + Vincristine DCK1VXN SCH 727965 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Thioguanine + Vincristine DC6GEYF Thioguanine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Thioguanine + Vincristine DCVBM2B Thioguanine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Thioguanine + Vincristine DCUMSR6 Thioguanine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Thioguanine + Vincristine DCV5SNH Thioguanine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Thioguanine + Vincristine DC5QG4P Thioguanine Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Thioguanine + Vincristine DC784KE Thioguanine Clear cell renal cell carcinoma (Cell Line: A498) [3]
Thioguanine + Vincristine DCQ2JU8 Thioguanine Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Thioguanine + Vincristine DCGHNZD Thioguanine Glioma (Cell Line: SF-295) [3]
Thioguanine + Vincristine DCAEDRB Thioguanine Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Thioguanine + Vincristine DC6LHLZ Thioguanine Renal cell carcinoma (Cell Line: SN12C) [3]
Thioguanine + Vincristine DC2BBEM Thioguanine Adenocarcinoma (Cell Line: DU-145) [5]
Thioguanine + Vincristine DCUUJMY Thioguanine Adenocarcinoma (Cell Line: OVCAR3) [5]
Thioguanine + Vincristine DC2XM9J Thioguanine Adenocarcinoma (Cell Line: A549) [5]
Thioguanine + Vincristine DCL81ZA Thioguanine Adenocarcinoma (Cell Line: HCT-15) [5]
Thioguanine + Vincristine DCJJ0K2 Thioguanine Amelanotic melanoma (Cell Line: M14) [5]
Thioguanine + Vincristine DCDZ06U Thioguanine Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Thioguanine + Vincristine DCDKOS1 Thioguanine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Thioguanine + Vincristine DCZJBJ8 Thioguanine Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Thioguanine + Vincristine DCE9Z4Y Thioguanine Malignant melanoma (Cell Line: LOX IMVI) [5]
Thioguanine + Vincristine DCMSZFP Thioguanine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Thioguanine + Vincristine DCBJ9XD Thioguanine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Thioguanine + Vincristine DC8PHJA Thioguanine Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Thioguanine + Vincristine DCSJBCD Thioguanine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Topotecan + Vincristine DC3KEPV Topotecan Adenocarcinoma (Cell Line: A549) [5]
Topotecan + Vincristine DCMQS1X Topotecan Adenocarcinoma (Cell Line: HT29) [5]
Topotecan + Vincristine DC8SWI7 Topotecan Amelanotic melanoma (Cell Line: M14) [5]
Topotecan + Vincristine DCURQ9A Topotecan Anaplastic large cell lymphoma (Cell Line: SR) [5]
Topotecan + Vincristine DCVU5WW Topotecan Clear cell renal cell carcinoma (Cell Line: A498) [5]
Topotecan + Vincristine DCLO8Q7 Topotecan Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Topotecan + Vincristine DC9J98Q Topotecan Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Trifluridine + Vincristine DC2YTOB Trifluridine Clear cell renal cell carcinoma (Cell Line: A498) [3]
Trifluridine + Vincristine DCRD3AF Trifluridine Adenocarcinoma (Cell Line: A549) [5]
Trifluridine + Vincristine DC0FFX2 Trifluridine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Uracil mustard + Vincristine DCNBPTD Uracil mustard Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Uracil mustard + Vincristine DC3BBSK Uracil mustard Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Uracil mustard + Vincristine DCUU940 Uracil mustard Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Vincristine DCRYGZ5 Uracil mustard Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Uracil mustard + Vincristine DC8X84L Uracil mustard Glioma (Cell Line: SF-295) [3]
Uracil mustard + Vincristine DCYSEXO Uracil mustard Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Uracil mustard + Vincristine DCIDK4A Uracil mustard Colon adenocarcinoma (Cell Line: COLO 205) [4]
Uracil mustard + Vincristine DC6TTV8 Uracil mustard Adenocarcinoma (Cell Line: DU-145) [5]
Uracil mustard + Vincristine DCO5YRY Uracil mustard Adenocarcinoma (Cell Line: A549) [5]
Uracil mustard + Vincristine DCL5TJG Uracil mustard Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Uracil mustard + Vincristine DCBX6XL Uracil mustard Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Uracil mustard + Vincristine DCDJ2MM Uracil mustard Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Vandetanib + Vincristine DCQ6T3N Vandetanib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Vandetanib + Vincristine DC5JWCU Vandetanib Adenocarcinoma (Cell Line: DU-145) [5]
Vandetanib + Vincristine DCPU3GE Vandetanib Adenocarcinoma (Cell Line: OVCAR3) [5]
Vandetanib + Vincristine DCQLVFF Vandetanib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Vandetanib + Vincristine DCEK1VY Vandetanib Lung adenocarcinoma (Cell Line: HOP-62) [5]
Vandetanib + Vincristine DC5OBRW Vandetanib Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Vandetanib + Vincristine DCZ8EAP Vandetanib Malignant melanoma (Cell Line: LOX IMVI) [5]
Vandetanib + Vincristine DCP3NTB Vandetanib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Vandetanib + Vincristine DC0WMT1 Vandetanib Renal cell carcinoma (Cell Line: SN12C) [5]
Vemurafenib + Vincristine DCKABA1 Vemurafenib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Vemurafenib + Vincristine DC5UWF8 Vemurafenib Adenocarcinoma (Cell Line: A549) [5]
Vemurafenib + Vincristine DCRNMFJ Vemurafenib Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Vemurafenib + Vincristine DC38M64 Vemurafenib Anaplastic large cell lymphoma (Cell Line: SR) [5]
Vemurafenib + Vincristine DCI1N4J Vemurafenib Clear cell renal cell carcinoma (Cell Line: TK-10) [5]
Vemurafenib + Vincristine DCBKY6H Vemurafenib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Vemurafenib + Vincristine DCOAZB9 Vemurafenib Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Vemurafenib + Vincristine DCG07QS Vemurafenib Melanoma (Cell Line: UACC-257) [5]
Vemurafenib + Vincristine DCL8Y3E Vemurafenib Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Vemurafenib + Vincristine DCT1W3L Vemurafenib Renal cell carcinoma (Cell Line: UO-31) [5]
Vincristine + Pentostatin DCS15D5 Pentostatin Adenocarcinoma (Cell Line: HT29) [3]
Vincristine + Pentostatin DC8N57C Pentostatin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Vincristine + Fulvestrant DCGCB29 Fulvestrant Adenocarcinoma (Cell Line: DU-145) [3]
Vincristine + Fulvestrant DCGPNNU Fulvestrant Adenocarcinoma (Cell Line: HT29) [3]
Vincristine + Fulvestrant DC27QD6 Fulvestrant Adenocarcinoma (Cell Line: HCT116) [3]
Vincristine + Fulvestrant DC8PSXB Fulvestrant Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Vincristine + Fulvestrant DC5SR63 Fulvestrant Glioma (Cell Line: SF-295) [3]
Vincristine + Fulvestrant DCHSV6O Fulvestrant High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Vincristine + Fulvestrant DCH82IB Fulvestrant Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Vincristine + Fulvestrant DC981IX Fulvestrant Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Vincristine + Fulvestrant DCML5Q0 Fulvestrant Prostate carcinoma (Cell Line: PC-3) [3]
Vincristine + Fulvestrant DCWU5YO Fulvestrant Renal cell carcinoma (Cell Line: UO-31) [3]
Vincristine + Buparlisib DCJPCMX Buparlisib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Vincristine + Ruxolitinib DCHRZ67 Ruxolitinib Hodgkin lymphoma (Cell Line: L-1236) [3]
Vincristine + Ruxolitinib DCI91NL Ruxolitinib T-cell leukemia/lymphoma (Cell Line: ED-40515) [3]
Vincristine + Hepzato DC6WFJ3 Hepzato Adenocarcinoma (Cell Line: HT29) [3]
Vincristine + Hepzato DCMEXVD Hepzato Clear cell renal cell carcinoma (Cell Line: A498) [3]
Vincristine + Hepzato DCJ9PL8 Hepzato Malignant melanoma (Cell Line: LOX IMVI) [3]
Vincristine + Hepzato DCFHBPF Hepzato Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Vincristine + Ixabepilone DCPCT0Z Ixabepilone Anaplastic large cell lymphoma (Cell Line: SR) [3]
Vincristine + Ixabepilone DCLLJVH Ixabepilone Glioma (Cell Line: SF-268) [3]
Vincristine + Ixabepilone DCF6WH8 Ixabepilone Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Vincristine + Dactinomycin DCCAJ6U Dactinomycin Adenocarcinoma (Cell Line: HCT-15) [3]
Vincristine + Dactinomycin DC51P9V Dactinomycin Adenocarcinoma (Cell Line: HCT116) [3]
Vincristine + Dactinomycin DC3FAQY Dactinomycin Glioma (Cell Line: SF-295) [3]
Vincristine + Dactinomycin DCFXCFV Dactinomycin Melanoma (Cell Line: MALME-3M) [3]
Vincristine + Dactinomycin DC1RUAO Dactinomycin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Vincristine + Lapatinib DC3CSL3 Lapatinib Adenocarcinoma (Cell Line: DU-145) [3]
Vincristine + Lapatinib DCS6AOK Lapatinib Adenocarcinoma (Cell Line: OVCAR3) [3]
Vincristine + Lapatinib DC2CW35 Lapatinib Adenocarcinoma (Cell Line: A549) [3]
Vincristine + Lapatinib DC7F25A Lapatinib Adenocarcinoma (Cell Line: HT29) [3]
Vincristine + Lapatinib DC9E34Q Lapatinib Adenocarcinoma (Cell Line: HCT-15) [3]
Vincristine + Lapatinib DCAXEWF Lapatinib Adenocarcinoma (Cell Line: HCT116) [3]
Vincristine + Lapatinib DC7SW5S Lapatinib Clear cell renal cell carcinoma (Cell Line: A498) [3]
Vincristine + Lapatinib DCFX50Q Lapatinib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Vincristine + Lapatinib DCV4YT8 Lapatinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Vincristine + Lapatinib DCFVIES Lapatinib Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Vincristine + Lapatinib DCWICSW Lapatinib Glioma (Cell Line: SF-268) [3]
Vincristine + Lapatinib DC0FN9T Lapatinib Glioma (Cell Line: SF-295) [3]
Vincristine + Lapatinib DCYF3AJ Lapatinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Vincristine + Lapatinib DC63BGT Lapatinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Vincristine + Lapatinib DCLQ3GA Lapatinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Vincristine + Lapatinib DC1YV4Y Lapatinib Lung adenocarcinoma (Cell Line: HOP-62) [3]
Vincristine + Lapatinib DCMWEFA Lapatinib Lung adenocarcinoma (Cell Line: EKVX) [3]
Vincristine + Lapatinib DC7EVSN Lapatinib Melanoma (Cell Line: UACC-257) [3]
Vincristine + Lapatinib DCD56FH Lapatinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Vincristine + Lapatinib DCKPCHI Lapatinib Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Vincristine + Lapatinib DCO5VI5 Lapatinib Prostate carcinoma (Cell Line: PC-3) [3]
Vincristine + Lapatinib DCRQUU8 Lapatinib Renal cell carcinoma (Cell Line: SN12C) [3]
Vincristine + Carfilzomib DCNDTI5 Carfilzomib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Vincristine + PMID28460551-Compound-2 DCLUOLM PMID28460551-Compound-2 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Vincristine + PMID28460551-Compound-2 DCH4AQF PMID28460551-Compound-2 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Vincristine + PMID28460551-Compound-2 DCS2Y27 PMID28460551-Compound-2 Glioma (Cell Line: SF-268) [3]
Vincristine + Crizotinib DCLBKHS Crizotinib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Vincristine + Cyclophosphamide DCARX9G Cyclophosphamide Adenocarcinoma (Cell Line: DU-145) [3]
Vincristine + Cyclophosphamide DCTOLNK Cyclophosphamide Adenocarcinoma (Cell Line: OVCAR3) [3]
Vincristine + Cyclophosphamide DCVLHCS Cyclophosphamide Adenocarcinoma (Cell Line: HCC-2998) [3]
Vincristine + Cyclophosphamide DCETRM8 Cyclophosphamide Adenocarcinoma (Cell Line: SW-620) [3]
Vincristine + Cyclophosphamide DCTYQLK Cyclophosphamide Adenocarcinoma (Cell Line: HT29) [3]
Vincristine + Cyclophosphamide DCSAYUD Cyclophosphamide Astrocytoma (Cell Line: SNB-19) [3]
Vincristine + Cyclophosphamide DCCDF0A Cyclophosphamide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Vincristine + Cyclophosphamide DCF5JOK Cyclophosphamide Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Vincristine + Cyclophosphamide DC0CPV6 Cyclophosphamide Lung adenocarcinoma (Cell Line: HOP-62) [3]
Vincristine + Cyclophosphamide DC55VAW Cyclophosphamide Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Vincristine + Panobinostat DC9WFXA Panobinostat Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Vincristine + Panobinostat DC12Y56 Panobinostat Hodgkin lymphoma (Cell Line: L-1236) [3]
Vincristine + Ym155 DCNELSS Ym155 Hodgkin lymphoma (Cell Line: L-1236) [3]
Vincristine + Ixazomib DC3ZWFB Ixazomib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Vincristine + Arsenic trioxide DCF2KPR Arsenic trioxide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Vincristine + Arsenic trioxide DC12ASV Arsenic trioxide Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Vincristine + Arsenic trioxide DCI6HVH Arsenic trioxide Astrocytoma (Cell Line: U251) [3]
Vincristine + Arsenic trioxide DCW1JNP Arsenic trioxide Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Vincristine + Arsenic trioxide DCGJVZQ Arsenic trioxide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Vincristine + Arsenic trioxide DCWFCOF Arsenic trioxide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Vincristine + Arsenic trioxide DCT6DR5 Arsenic trioxide Melanoma (Cell Line: UACC-257) [3]
Vincristine + Arsenic trioxide DC9HTM1 Arsenic trioxide Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Vincristine + Fomepizole DCOZKVM Fomepizole Hodgkin lymphoma (Cell Line: L-1236) [3]
Vincristine + Plicamycin DCM71N1 Plicamycin Adenocarcinoma (Cell Line: OVCAR3) [3]
Vincristine + Plicamycin DCVT1HB Plicamycin Adenocarcinoma (Cell Line: NCIH23) [3]
Vincristine + Plicamycin DCDGWBY Plicamycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Vincristine + Plicamycin DC5B7NS Plicamycin Hodgkin lymphoma (Cell Line: L-1236) [3]
Vincristine + Plicamycin DC9KQ2L Plicamycin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Vincristine + Nilotinib DC65CHW Nilotinib Adenocarcinoma (Cell Line: DU-145) [3]
Vincristine + Nilotinib DCZU3PS Nilotinib Adenocarcinoma (Cell Line: A549) [3]
Vincristine + Nilotinib DCQ33B9 Nilotinib Adenocarcinoma (Cell Line: HT29) [3]
Vincristine + Nilotinib DC92QTD Nilotinib Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Vincristine + Nilotinib DCG9468 Nilotinib Amelanotic melanoma (Cell Line: M14) [3]
Vincristine + Nilotinib DCL0QSR Nilotinib Astrocytoma (Cell Line: U251) [3]
Vincristine + Nilotinib DC0INED Nilotinib Clear cell renal cell carcinoma (Cell Line: A498) [3]
Vincristine + Nilotinib DCRAEEJ Nilotinib Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Vincristine + Nilotinib DCAZJNA Nilotinib Glioma (Cell Line: SF-539) [3]
Vincristine + Nilotinib DCZPGXX Nilotinib Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Vincristine + Nilotinib DC248P8 Nilotinib Lung adenocarcinoma (Cell Line: HOP-62) [3]
Vincristine + Nilotinib DC6Z1A6 Nilotinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Vincristine + Nilotinib DCMDZ0G Nilotinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Vincristine + Nilotinib DCVCB0R Nilotinib Prostate carcinoma (Cell Line: PC-3) [3]
Vincristine + Triapine DC7X4AM Triapine Adenocarcinoma (Cell Line: HT29) [3]
Vincristine + Triapine DCVR0VB Triapine Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Vincristine + Triapine DCTJOY9 Triapine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Vincristine + Triapine DCN11HC Triapine Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Vincristine + Triapine DCPY5U0 Triapine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Vincristine + 10-hydroxycamptothecin DCGE2HJ 10-hydroxycamptothecin Amelanotic melanoma (Cell Line: M14) [3]
Vincristine + 10-hydroxycamptothecin DCQRUSU 10-hydroxycamptothecin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Vincristine + GDC-0084 DCM2ANZ GDC-0084 Hodgkin lymphoma (Cell Line: L-1236) [3]
Vincristine + Topetecan DC89OAP Topetecan Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Vincristine + SCH 727965 DCRHYS0 SCH 727965 Adenocarcinoma (Cell Line: DU-145) [3]
Vincristine + SCH 727965 DC8VKYN SCH 727965 Adenocarcinoma (Cell Line: HT29) [3]
Vincristine + SCH 727965 DCX1KBN SCH 727965 Adenocarcinoma (Cell Line: SW-620) [3]
Vincristine + SCH 727965 DCT67TD SCH 727965 Adenocarcinoma (Cell Line: HCT116) [3]
Vincristine + SCH 727965 DCDMNLJ SCH 727965 Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Vincristine + SCH 727965 DCFHPS8 SCH 727965 Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Vincristine + SCH 727965 DC8W0W6 SCH 727965 Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Vincristine + SCH 727965 DCQ8VNF SCH 727965 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Vincristine + SCH 727965 DCW6MGX SCH 727965 Hodgkin lymphoma (Cell Line: L-1236) [3]
Vincristine + SCH 727965 DC9DARY SCH 727965 Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Vincristine + SCH 727965 DC500M2 SCH 727965 Lung adenocarcinoma (Cell Line: HOP-62) [3]
Vincristine + SCH 727965 DCJFCXB SCH 727965 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Vincristine + SCH 727965 DCP09B4 SCH 727965 Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Vincristine + SCH 727965 DCCRP1I SCH 727965 Renal cell carcinoma (Cell Line: SN12C) [3]
Vincristine + Ifosfamide DC1ZOB1 Ifosfamide Adenocarcinoma (Cell Line: DU-145) [3]
Vincristine + Ifosfamide DCL1W2O Ifosfamide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Vincristine + Ifosfamide DCVZY9D Ifosfamide Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Vincristine + Ifosfamide DCUCR0P Ifosfamide Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Vincristine + Ifosfamide DCX9H0R Ifosfamide Prostate carcinoma (Cell Line: PC-3) [3]
Vincristine + Ifosfamide DC7055V Ifosfamide Renal cell carcinoma (Cell Line: SN12C) [3]
Vincristine + Docetaxel DCJ8PRV Docetaxel Adenocarcinoma (Cell Line: DU-145) [3]
Vincristine + Docetaxel DCLQ2VV Docetaxel Clear cell renal cell carcinoma (Cell Line: A498) [3]
Vincristine + Docetaxel DCNUIL6 Docetaxel High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Vincristine + Raloxifene DCQ0DUX Raloxifene Adenocarcinoma (Cell Line: DU-145) [3]
Vincristine + Raloxifene DCOR1JK Raloxifene Adenocarcinoma (Cell Line: HCT116) [3]
Vincristine + Raloxifene DC2179Q Raloxifene Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Vincristine + Raloxifene DCFRF7E Raloxifene Amelanotic melanoma (Cell Line: M14) [3]
Vincristine + Raloxifene DCPLM1E Raloxifene High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Vincristine + Raloxifene DC8AY3T Raloxifene Malignant melanoma (Cell Line: UACC62) [3]
Vincristine + Raloxifene DCNUL93 Raloxifene Prostate carcinoma (Cell Line: PC-3) [3]
Vincristine + Bendamustine hydrochloride DCU3AEL Bendamustine hydrochloride Adenocarcinoma (Cell Line: HCT116) [3]
Vincristine + Bendamustine hydrochloride DCS8RZT Bendamustine hydrochloride Adenocarcinoma (Cell Line: HCT-15) [3]
Vincristine + Bendamustine hydrochloride DC23VSG Bendamustine hydrochloride Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Vincristine + Bendamustine hydrochloride DC0DVLK Bendamustine hydrochloride Melanoma (Cell Line: MALME-3M) [3]
Vincristine + Bendamustine hydrochloride DC9EDSH Bendamustine hydrochloride Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Vincristine + Withaferin A DC5U7HT Withaferin A Hodgkin lymphoma (Cell Line: L-1236) [3]
Vincristine + Sirolimus DCD5549 Sirolimus Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Vincristine + Sirolimus DCAJF42 Sirolimus Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Vincristine + Sirolimus DCLJEGR Sirolimus Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Vincristine + Sirolimus DCKKAGG Sirolimus Malignant melanoma (Cell Line: LOX IMVI) [3]
Vincristine + Sirolimus DCCGXGX Sirolimus Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Vincristine + Sirolimus DC876GI Sirolimus Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Vincristine + Sirolimus DCY7N4B Sirolimus Renal cell carcinoma (Cell Line: UO-31) [3]
Vincristine + Mitomycin DC9GK7C Mitomycin Adenocarcinoma (Cell Line: A549) [3]
Vincristine + Mitomycin DCOWIJD Mitomycin Adenocarcinoma (Cell Line: HT29) [3]
Vincristine + Mitomycin DCR7QYK Mitomycin Adenocarcinoma (Cell Line: HCT-15) [3]
Vincristine + Mitomycin DCBYMPU Mitomycin Diffuse large B cell lymphoma (Cell Line: TMD8) [3]
Vincristine + Mitomycin DCU4LNB Mitomycin Glioma (Cell Line: SF-539) [3]
Vincristine + Mitomycin DCD77GR Mitomycin High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Vincristine + Mitomycin DCU3B5Z Mitomycin Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Vincristine + SY-1425 DC1ETZF SY-1425 Adenocarcinoma (Cell Line: HCT-15) [3]
Vincristine + SY-1425 DCA6IDN SY-1425 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Vincristine + SY-1425 DCP883V SY-1425 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Vincristine + SY-1425 DCU630R SY-1425 Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Vincristine + Pelitinib DC72IAJ Pelitinib Hodgkin lymphoma (Cell Line: U-HO1) [3]
Vincristine + Altretamine DCBQREG Altretamine Amelanotic melanoma (Cell Line: M14) [3]
Vincristine + Altretamine DCBGQZE Altretamine Astrocytoma (Cell Line: U251) [3]
Vincristine + Altretamine DCZ4W1R Altretamine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Vincristine + TEM DCJO0F3 TEM Adenocarcinoma (Cell Line: DU-145) [3]
Vincristine + TEM DCFZMBV TEM Astrocytoma (Cell Line: SNB-19) [3]
Vincristine + TEM DCA5AHJ TEM Prostate carcinoma (Cell Line: PC-3) [3]
Vincristine + Idarubicin DCK3Q4L Idarubicin Adenocarcinoma (Cell Line: A549) [3]
Vincristine + Idarubicin DC8U37M Idarubicin Adenocarcinoma (Cell Line: HCT-15) [3]
Vincristine + Idarubicin DCTPOLX Idarubicin Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Vincristine + Idarubicin DCWKI9T Idarubicin High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Vincristine + Idarubicin DCYDFDL Idarubicin Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Vincristine + Idarubicin DCKVGQF Idarubicin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Vincristine + Idarubicin DCR53AX Idarubicin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Vincristine + Idarubicin DCYRGFI Idarubicin Prostate carcinoma (Cell Line: PC-3) [3]
Vincristine + Imatinib DCNR7FT Imatinib Adenocarcinoma (Cell Line: HT29) [3]
Vincristine + Imatinib DCR1N8B Imatinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Vincristine + Imatinib DCSCR2C Imatinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Vincristine + Imatinib DC1KNM0 Imatinib Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Vincristine + Azathioprine DCVT8AY Azathioprine Hodgkin lymphoma (Cell Line: L-1236) [3]
Vincristine + Bleomycin DCX1278 Bleomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Vincristine + Bleomycin DC3N3C9 Bleomycin Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Vincristine + Bleomycin DCKWMCP Bleomycin Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Vincristine + Bortezomib DC0C2CN Bortezomib Hodgkin lymphoma (Cell Line: L-1236) [3]
Vincristine + IMD-0354 DCFBWD1 IMD-0354 Hodgkin lymphoma (Cell Line: L-1236) [3]
Vincristine + Valrubicin DCJH7AX Valrubicin Adenocarcinoma (Cell Line: NCIH23) [3]
Vincristine + Valrubicin DC2J0T4 Valrubicin Adenocarcinoma (Cell Line: HCT-15) [3]
Vincristine + Valrubicin DCBJBGH Valrubicin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Vincristine + Valrubicin DCVZTJK Valrubicin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Vincristine + Valrubicin DCZIMGV Valrubicin Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Vincristine + Valrubicin DC5RDFH Valrubicin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Vincristine + Valrubicin DCW89YX Valrubicin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Vincristine + Valrubicin DCPONKH Valrubicin Prostate carcinoma (Cell Line: PC-3) [3]
Vincristine + BMS-754807 DCGU2LS BMS-754807 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Vincristine + Cisplatin DCCRXR3 Cisplatin Adenocarcinoma (Cell Line: HCT-15) [3]
Vincristine + Cisplatin DCKVWOK Cisplatin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Vincristine + Cisplatin DCC4PY0 Cisplatin Glioma (Cell Line: SF-295) [3]
Vincristine + Chlorambucil DCR58C2 Chlorambucil Adenocarcinoma (Cell Line: HCT116) [3]
Vincristine + Chlorambucil DCQW9RN Chlorambucil High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Vincristine + Sorafenib DCBRIBM Sorafenib Adenocarcinoma (Cell Line: DU-145) [3]
Vincristine + Sorafenib DC144DL Sorafenib Adenocarcinoma (Cell Line: HT29) [3]
Vincristine + Sorafenib DCES7ZH Sorafenib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Vincristine + Sorafenib DC9IFTA Sorafenib Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Vincristine + ER819762 DC94QAO ER819762 Adenocarcinoma (Cell Line: A549) [3]
Vincristine + ER819762 DC906PJ ER819762 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Vincristine + Romidepsin DCD4MG3 Romidepsin Adenocarcinoma (Cell Line: NCIH23) [3]
Vincristine + Azacitidine DC9ZNKG Azacitidine Glioma (Cell Line: SF-268) [3]
Vincristine + Azacitidine DC5EVUQ Azacitidine Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Vincristine + Azacitidine DCSBI2I Azacitidine Malignant melanoma (Cell Line: UACC62) [3]
Vincristine + Vinflunine DCXF21V Vinflunine Adenocarcinoma (Cell Line: NCIH23) [3]
Vincristine + Vinflunine DCCRSV8 Vinflunine Adenocarcinoma (Cell Line: HT29) [3]
Vincristine + Vinflunine DC4MVMM Vinflunine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Vincristine + Vinflunine DCDUCO8 Vinflunine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Vincristine + Vinflunine DCRPUT5 Vinflunine Astrocytoma (Cell Line: U251) [3]
Vincristine + Vinflunine DCBNH10 Vinflunine Glioma (Cell Line: SF-539) [3]
Vincristine + Vinflunine DCTLEGV Vinflunine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Vincristine + Vinflunine DCJEA27 Vinflunine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Vincristine + Vinflunine DCFOF9R Vinflunine Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Vincristine + Vinflunine DCSSU4K Vinflunine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Vincristine + Vinflunine DC0HUQV Vinflunine Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Vincristine + Mercaptopurine DCYJZJZ Mercaptopurine Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Vincristine + Mercaptopurine DCSA5T9 Mercaptopurine Glioma (Cell Line: SF-295) [3]
Vincristine + Mepacrine DCB1Y9I Mepacrine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Vincristine + Mepacrine DC0DQAH Mepacrine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Vincristine + Mepacrine DCDJAJE Mepacrine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Vincristine + Mepacrine DCGM7D1 Mepacrine Lung adenocarcinoma (Cell Line: HOP-62) [3]
Vincristine + Mepacrine DCGDJPX Mepacrine Malignant melanoma (Cell Line: UACC62) [3]
Vincristine + AZD8330 DC3XR9R AZD8330 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Vincristine + Taxol DCHO5GA Taxol Chronic myelogenous leukemia (Cell Line: K-562) [3]
Vincristine + Taxol DCWJ3V3 Taxol High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Vincristine + Taxol DC8XQFZ Taxol Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Vincristine + CP-673451 DCI4B2L CP-673451 Hodgkin lymphoma (Cell Line: L-1236) [3]
Vincristine + PMID28870136-Compound-43 DCC5XD0 PMID28870136-Compound-43 Adenocarcinoma (Cell Line: HCT-15) [3]
Vincristine + PMID28870136-Compound-43 DCBMTOP PMID28870136-Compound-43 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Vincristine + PMID28870136-Compound-43 DCE1HPY PMID28870136-Compound-43 Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Vincristine + FORMESTANE DCAJ727 FORMESTANE Adenocarcinoma (Cell Line: A549) [3]
Vincristine + FORMESTANE DC51J33 FORMESTANE Adenocarcinoma (Cell Line: HCT116) [3]
Vincristine + FORMESTANE DCVB7CL FORMESTANE Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Vincristine + FORMESTANE DCFCG7U FORMESTANE High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Vincristine + Vorinostat DCH0OXD Vorinostat Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Vincristine + Aminolevulinic Acid Hydrochloride DCPN8RS Aminolevulinic Acid Hydrochloride Adenocarcinoma (Cell Line: HCT116) [3]
Vincristine + Aminolevulinic Acid Hydrochloride DC0RZWD Aminolevulinic Acid Hydrochloride Adenocarcinoma (Cell Line: HCC-2998) [3]
Vincristine + Aminolevulinic Acid Hydrochloride DCN2IO6 Aminolevulinic Acid Hydrochloride Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Vincristine + Aminolevulinic Acid Hydrochloride DCY0DOR Aminolevulinic Acid Hydrochloride Astrocytoma (Cell Line: U251) [3]
Vincristine + Aminolevulinic Acid Hydrochloride DC5IFWU Aminolevulinic Acid Hydrochloride Astrocytoma (Cell Line: SNB-19) [3]
Vincristine + Aminolevulinic Acid Hydrochloride DC25TPK Aminolevulinic Acid Hydrochloride Chronic myelogenous leukemia (Cell Line: K-562) [3]
Vincristine + Aminolevulinic Acid Hydrochloride DCSWF49 Aminolevulinic Acid Hydrochloride Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Vincristine + Aminolevulinic Acid Hydrochloride DCNTO37 Aminolevulinic Acid Hydrochloride Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Vincristine + Estramustine DCNRRYO Estramustine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Vincristine + Estramustine DCKVDRT Estramustine Lung adenocarcinoma (Cell Line: HOP-62) [3]
Vincristine + BGT226 DCBK8UV BGT226 Hodgkin lymphoma (Cell Line: L-1236) [3]
Vincristine + Busulfan DC3OSUX Busulfan Adenocarcinoma (Cell Line: DU-145) [3]
Vincristine + Busulfan DC3JP64 Busulfan Adenocarcinoma (Cell Line: HCC-2998) [3]
Vincristine + Busulfan DCPG5VL Busulfan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Vincristine + Busulfan DCCTJCR Busulfan Amelanotic melanoma (Cell Line: M14) [3]
Vincristine + Busulfan DC43Y43 Busulfan High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Vincristine + Busulfan DC0JPIL Busulfan Melanoma (Cell Line: UACC-257) [3]
Vincristine + Ibrutinib DCEKV5U Ibrutinib Diffuse large B cell lymphoma (Cell Line: TMD8) [3]
Vincristine + Dasatinib DCPE3KK Dasatinib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Vincristine + Dasatinib DC7IQKZ Dasatinib Glioma (Cell Line: SF-539) [3]
Vincristine + Dasatinib DCYI0WG Dasatinib Glioma (Cell Line: SF-268) [3]
Vincristine + Dasatinib DCJRRCC Dasatinib Malignant melanoma (Cell Line: LOX IMVI) [3]
Vincristine + Dasatinib DCAQ79Y Dasatinib Renal cell carcinoma (Cell Line: SN12C) [3]
Vincristine + Pentostatin DCSRH1T Pentostatin Colon adenocarcinoma (Cell Line: COLO 205) [4]
Vincristine + Fulvestrant DCRU2DN Fulvestrant Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Vincristine + Fulvestrant DCTSG8L Fulvestrant Colon adenocarcinoma (Cell Line: COLO 205) [4]
Vincristine + Fulvestrant DCYWNEF Fulvestrant Invasive ductal carcinoma (Cell Line: T-47D) [4]
Vincristine + Hepzato DC64KAM Hepzato Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Vincristine + Lapatinib DCSJ0U9 Lapatinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Vincristine + Lapatinib DC7AJIN Lapatinib Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Vincristine + Lapatinib DC2OUYJ Lapatinib Invasive ductal carcinoma (Cell Line: T-47D) [4]
Vincristine + Cyclophosphamide DCPM983 Cyclophosphamide Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Vincristine + Cyclophosphamide DCI7N9N Cyclophosphamide Carcinoma (Cell Line: MCF7) [4]
Vincristine + Cyclophosphamide DCPITCI Cyclophosphamide Colon carcinoma (Cell Line: KM12) [4]
Vincristine + Cyclophosphamide DCG082W Cyclophosphamide Invasive ductal carcinoma (Cell Line: BT-549) [4]
Vincristine + Arsenic trioxide DCMATW5 Arsenic trioxide Invasive ductal carcinoma (Cell Line: T-47D) [4]
Vincristine + Nilotinib DC81L1L Nilotinib Colon carcinoma (Cell Line: KM12) [4]
Vincristine + Triapine DC3YUU2 Triapine Invasive ductal carcinoma (Cell Line: BT-549) [4]
Vincristine + SCH 727965 DCWATS7 SCH 727965 Colon adenocarcinoma (Cell Line: COLO 205) [4]
Vincristine + SCH 727965 DC23Z3M SCH 727965 Invasive ductal carcinoma (Cell Line: T-47D) [4]
Vincristine + Ifosfamide DCFJLDU Ifosfamide Colon adenocarcinoma (Cell Line: COLO 205) [4]
Vincristine + Ifosfamide DCFUQXN Ifosfamide Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Vincristine + Ifosfamide DC38UEZ Ifosfamide Invasive ductal carcinoma (Cell Line: T-47D) [4]
Vincristine + Bendamustine hydrochloride DCW3TZH Bendamustine hydrochloride Colon adenocarcinoma (Cell Line: COLO 205) [4]
Vincristine + TEM DCR1861 TEM Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Vincristine + Valrubicin DCQYGMV Valrubicin Carcinoma (Cell Line: RXF 393) [4]
Vincristine + Valrubicin DCM5MBC Valrubicin Invasive ductal carcinoma (Cell Line: T-47D) [4]
Vincristine + Digitoxin DCEDT1D Digitoxin Invasive ductal carcinoma (Cell Line: T-47D) [4]
Vincristine + Busulfan DCXU1EC Busulfan Colon carcinoma (Cell Line: KM12) [4]
Vismodegib + Vincristine DCMM6N2 Vismodegib Carcinoma (Cell Line: RXF 393) [4]
Vismodegib + Vincristine DCCGQHA Vismodegib Carcinoma (Cell Line: MCF7) [4]
Vismodegib + Vincristine DCNV8YQ Vismodegib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Vismodegib + Vincristine DCCZZ5C Vismodegib Adenocarcinoma (Cell Line: OVCAR3) [5]
Vismodegib + Vincristine DCLT2WK Vismodegib Adenocarcinoma (Cell Line: A549) [5]
Vismodegib + Vincristine DCG0237 Vismodegib Adenocarcinoma (Cell Line: HCT-15) [5]
Vismodegib + Vincristine DC0YRT2 Vismodegib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Vismodegib + Vincristine DC4K4JQ Vismodegib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Vismodegib + Vincristine DCV5G6W Vismodegib Anaplastic large cell lymphoma (Cell Line: SR) [5]
Vismodegib + Vincristine DCCWE5A Vismodegib Chronic myelogenous leukemia (Cell Line: K-562) [5]
Vismodegib + Vincristine DCXJLBB Vismodegib Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Vismodegib + Vincristine DCCLKQB Vismodegib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Vismodegib + Vincristine DC89N9B Vismodegib Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Vismodegib + Vincristine DCU4FVS Vismodegib Malignant melanoma (Cell Line: LOX IMVI) [5]
Vismodegib + Vincristine DCT3OM2 Vismodegib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Vismodegib + Vincristine DC8BZ7N Vismodegib Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Vismodegib + Vincristine DCPL9GS Vismodegib Renal cell carcinoma (Cell Line: SN12C) [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 599 DrugCom(s)
21 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Belinostat + Vincristine DCLDN0X Belinostat Peripheral T-cell Lymphoma [6]
Carboplatin + Vincristine DCETI1X Carboplatin Brain Tumor [7]
Carboplatin + Vincristine DC140UW Carboplatin Brain Tumors [8]
Carboplatin + Vincristine DCYNRYE Carboplatin Pilomyxoid Astrocytoma [9]
Dexamethasone + Vincristine DC1K0UI Dexamethasone Non-Hodgkins Lymphoma [10]
Etoposide + Vincristine DCZYELT Etoposide Brain Tumors [11]
Etoposide + Vincristine DCMCVSB Etoposide Brain Tumors [12]
Metformin + Vincristine DCHDW34 Metformin Solid Tumors [13]
Regorafenib + Vincristine DC6NGTV Regorafenib Pediatric Oncology [14]
Regorafenib + Vincristine DCY85D6 Regorafenib Rhabdomyosarcoma [15]
Vincristine + Irinotecan DCSJ186 Irinotecan Unspecified Childhood Solid Tumor, Protocol Specific [16]
Vincristine + Temozolomide DC5P04O Temozolomide Brain and Central Nervous System Tumors [17]
Vincristine + Temozolomide DCU3LWE Temozolomide Rhabdomyosarcoma [15]
Vincristine + GS-9973 DCPLEEH GS-9973 Non-Hodgkin Lymphoma [18]
Nedaplatin + Vincristine DCTG8ZX Nedaplatin Central Nervous System Tumors [19]
Procarbazine + Vincristine DC487YF Procarbazine Brain and Central Nervous System Tumors [20]
Vincristine + Cytarabine DCHWBTR Cytarabine Hodgkin Disease [21]
Vincristine + Irinotecan DCKW02P Irinotecan Neuroblastoma [22]
Vincristine + Temozolomide DCMOCWO Temozolomide Ewing Sarcoma [23]
Cyclophosphamide + Vincristine DCEEEZI Cyclophosphamide Untreated Childhood Medulloblastoma [24]
Procarbazine + Vincristine DC98V7V Procarbazine Brain and Central Nervous System Tumors [25]
------------------------------------------------------------------------------------
⏷ Show the Full List of 21 DrugCom(s)

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6785).
2 Vincristine FDA Label
3 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
4 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
5 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
6 ClinicalTrials.gov (NCT01839097) Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL)
7 ClinicalTrials.gov (NCT00077207) Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
8 ClinicalTrials.gov (NCT00002944) Combination Chemotherapy in Treating Children With Progressive Brain Tumors
9 ClinicalTrials.gov (NCT01837862) A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
10 ClinicalTrials.gov (NCT00718757) Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies
11 ClinicalTrials.gov (NCT00003935) Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
12 ClinicalTrials.gov (NCT00003625) Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma
13 ClinicalTrials.gov (NCT01528046) Metformin in Children With Relapsed or Refractory Solid Tumors
14 ClinicalTrials.gov (NCT02085148) A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard Therapy
15 ClinicalTrials.gov (NCT04625907) FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
16 ClinicalTrials.gov (NCT00006095) Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy
17 ClinicalTrials.gov (NCT00138216) Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors
18 ClinicalTrials.gov (NCT02568683) Safety and Efficacy of Entospletinib (ENTO [GS-9973]) Combined With Vincristine (VCR) in Adult Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL)
19 ClinicalTrials.gov (NCT01735747) Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma
20 ClinicalTrials.gov (NCT00002806) Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
21 ClinicalTrials.gov (NCT01858922) Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A
22 ClinicalTrials.gov (NCT02035137) 131I-MIBG Alone VS. 131I-MIBG With Vincristine and Irinotecan VS131I-MIBG With Vorinostat
23 ClinicalTrials.gov (NCT03359005) Irinotecan and Temozolomide for Ewing Sarcoma
24 ClinicalTrials.gov (NCT00085735) Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
25 ClinicalTrials.gov (NCT00002569) Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma